Malamut Richard

SEC Form 4 insider trading activity

Malamut Richard has filed 2 SEC Form 4 filings (5 transaction rows) across 1 company, with disclosures dating back to 2026. 2 of those filings fall inside the rolling window. Most recent filing: Apr 6, 2026.

On the most recent filing, Malamut Richard is listed as Director at Pelthos Therapeutics Inc. Inside the rolling window, Malamut Richard reported no open-market purchases and 1 open-market sale totaling $12K in PTHS.

Companies traded

Other insiders at PTHS

Insider Buying

$0

reported purchases (SEC code P)

Insider Selling

$12K

reported sales (SEC code S)

Companies

1

in the rolling window

Source
PTHSSale$12KApr 6SEC ↗
Showing 1–1 of 1
1 / 1

Frequently asked questions

How many SEC Form 4 filings has Malamut Richard made?

Malamut Richard has filed 2 SEC Form 4 filings (5 transaction rows) across 1 company since 2026.

Which companies does Malamut Richard trade?

Malamut Richard has filed SEC Form 4 disclosures for 1 company, including PTHS.

When was Malamut Richard's most recent SEC Form 4 filing?

Malamut Richard's most recent SEC Form 4 filing on Tracefour is dated Apr 6, 2026.

What is Malamut Richard's total buy and sell value in the current window?

Inside the rolling retention window, Malamut Richard bought $0 and sold $12K based on SEC Form 4 filings.

What was Malamut Richard's largest disclosed transaction?

The largest disclosed transaction in the current window is a sale of 590 PTHS shares on 2026-04-02, worth $12K, per SEC Form 4 filings.